Wisdomtree Issuer ICAV - Wisdomtree Biorevolution UCITS ETF (ETR:WRNA)

Assets	31.81M
Expense Ratio	0.45%
PE Ratio	17.18
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+70.15%

Volume	3,888
Open	23.11
Previous Close	23.05
Day's Range	23.11 - 23.77
52-Week Low	13.73
52-Week High	23.77
Beta	n/a
Holdings	86
Inception Date	Dec 3, 2021

About WRNA

WBIO.IR was created on 2021-12-03 by WisdomTree. The fund's investment portfolio concentrates primarily on theme equity. The WisdomTree BioRevolution UCITS ETF (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (the Index).

• Asset Class: Equity
• Category: Theme
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: WRNA
• Provider: WisdomTree
• Index Tracked: WisdomTree Battery Solutions Index

Performance

WRNA had a total return of 70.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 0.95%.

Top 10 Holdings

44.66% of assets

Name	Symbol	Weight
Cash W-O	n/a	11.92%
Moderna, Inc.	MRNA	8.03%
Twist Bioscience Corporation	TWST	7.49%
Eli Lilly and Company	LLY	3.11%
10x Genomics, Inc.	TXG	2.92%
Natera, Inc.	NTRA	2.48%
Johnson & Johnson	JNJ	2.45%
Tempus AI, Inc.	TEM	2.40%
Immunome, Inc.	IMNM	2.09%
United Therapeutics Corporation	UTHR	1.77%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error